- Home
- INDB vs RCUS Comparison
INDB vs RCUS Comparison
Compare INDB & RCUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | INDB | RCUS |
|---|---|---|
| Founded | 1907 | 2015 |
| Country | United States | United States |
| Employees | N/A | 601 |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.0B | 3.6B |
| IPO Year | 1994 | 2018 |
Fundamental Metrics
Financial Performance| Metric | INDB | RCUS |
|---|---|---|
| Price | $85.12 | $28.42 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 4 | 10 |
| Target Price | ★ $87.00 | $31.90 |
| AVG Volume (30 Days) | 426.5K | ★ 1.3M |
| Earning Date | 04-16-2026 | 05-05-2026 |
| Dividend Yield | ★ 3.32% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 1.63 | N/A |
| Revenue | N/A | ★ $247,000,000.00 |
| Revenue This Year | $33.83 | N/A |
| Revenue Next Year | $5.85 | $45.62 |
| P/E Ratio | $52.01 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $61.55 | $8.84 |
| 52 Week High | $87.50 | $31.74 |
Technical Indicators
Market Signals| Indicator | INDB | RCUS |
|---|---|---|
| Relative Strength Index (RSI) | 56.86 | 51.38 |
| Support Level | $79.58 | $20.20 |
| Resistance Level | $87.25 | $28.72 |
| Average True Range (ATR) | 1.82 | 1.33 |
| MACD | -0.10 | -0.16 |
| Stochastic Oscillator | 69.71 | 50.83 |
Price Performance
Historical ComparisonAbout INDB Independent Bank Corp.
Independent Bank Corp is a bank holding company and the sole shareholder of its bank, the Rockland Trust Company. Rockland is a community-oriented commercial bank. The bank provides a variety of banking, investment and financial services, operating with various retail branches, as well as a network of commercial and residential lending centers and investment management offices majorly in Eastern Massachusetts, Worcester County, and Rhode Island. The bank's loan portfolio constitutes the bulk of the bank's total assets. Its borrowers consist mostly of small to medium-size businesses and consumers, majority of which are made to its market area in eastern Massachusetts and Rhode Island. The bank's loan portfolio is predominantly in commercial loans.
About RCUS Arcus Biosciences Inc.
Arcus Biosciences Inc is a late clinical-stage biopharmaceutical company focused on developing differentiated molecules for patients with cancer and inflammatory and autoimmune diseases. Its product pipeline includes Domvanalimab, Quemliclustat, Casdatifan, Zimberelimab, among others. The company operates in one reportable and operating segment, which is the business of developing and commercializing differentiated therapies.